Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 3
1952 5
1953 5
1954 2
1955 2
1956 1
1957 5
1958 2
1959 1
1961 1
1964 2
1965 9
1966 10
1967 15
1968 9
1969 23
1970 9
1971 9
1972 19
1973 20
1974 13
1975 19
1976 15
1977 16
1978 17
1979 32
1980 28
1981 21
1982 35
1983 33
1984 34
1985 28
1986 46
1987 28
1988 39
1989 36
1990 39
1991 42
1992 54
1993 49
1994 64
1995 48
1996 35
1997 48
1998 44
1999 75
2000 65
2001 84
2002 79
2003 103
2004 91
2005 100
2006 134
2007 120
2008 133
2009 97
2010 115
2011 129
2012 137
2013 140
2014 143
2015 138
2016 141
2017 135
2018 132
2019 158
2020 151
2021 154
2022 137
2023 171
2024 66

Text availability

Article attribute

Article type

Publication date

Search Results

3,781 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature.
Loricera J, Tofade T, Prieto-Peña D, Romero-Yuste S, de Miguel E, Riveros-Frutos A, Ferraz-Amaro I, Labrador E, Maiz O, Becerra E, Narváez J, Galíndez-Agirregoikoa E, González-Fernández I, Urruticoechea-Arana A, Ramos-Calvo Á, López-Gutiérrez F, Castañeda S, Unizony S, Blanco R. Loricera J, et al. Arthritis Res Ther. 2024 Jun 5;26(1):116. doi: 10.1186/s13075-024-03314-9. Arthritis Res Ther. 2024. PMID: 38840219 Free PMC article. Review.
METHODS: Retrospective analysis of GCA patients treated with JAKi for relapsing disease at thirteen centers in Spain and one center in United States (01/2017-12/2022). Outcomes assessed included clinical remission, complete remission and safety. Clinical remission w …
METHODS: Retrospective analysis of GCA patients treated with JAKi for relapsing disease at thirteen centers in Spain and one center in Unite …
Eosinophilic granulomatous polyangiitis with central nervous system involvement in children: a case report and literature review.
Nie N, Liu L, Bai C, Wang D, Gao S, Liu J, Zhang R, Lin Y, Zhang Q, Chang H. Nie N, et al. Front Immunol. 2024 May 15;15:1406424. doi: 10.3389/fimmu.2024.1406424. eCollection 2024. Front Immunol. 2024. PMID: 38812515 Free PMC article. Review.
OBJECTIVE: To explore the clinical characteristics and treatment outcomes of children with central nervous system (CNS) involvement in eosinophilic granulomatosis with polyangiitis (EGPA). ...Bone marrow cytology demonstrated a significant increase in …
OBJECTIVE: To explore the clinical characteristics and treatment outcomes of children with central nervous system
Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update.
Unal D, Cam V, Emreol HE, Özen S. Unal D, et al. Paediatr Drugs. 2024 Jul;26(4):381-395. doi: 10.1007/s40272-024-00632-y. Epub 2024 May 28. Paediatr Drugs. 2024. PMID: 38805115 Review.
Some studies have shown that anti-ribosomal P antibodies have a low sensitivity for NPSLE and a limited contribution to the differentiation of different clinical entities. Treatment has two main goals: symptomatic relief and treatment of the disease itself. ...
Some studies have shown that anti-ribosomal P antibodies have a low sensitivity for NPSLE and a limited contribution to the differentiation …
Surgery for Central Nervous System Tuberculosis in Children.
Muzumdar D, Bansal P, Rai S, Bhatia K. Muzumdar D, et al. Adv Tech Stand Neurosurg. 2024;49:255-289. doi: 10.1007/978-3-031-42398-7_12. Adv Tech Stand Neurosurg. 2024. PMID: 38700688
Tuberculosis (TB) is the second most common cause of death due to a single infectious agent worldwide after COVID-19. Central nervous system tuberculosis is widely prevalent in the world, especially in the developing countries and continues to be a socioecono …
Tuberculosis (TB) is the second most common cause of death due to a single infectious agent worldwide after COVID-19. Central nerv
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patients.
Wallmeier P, Arnold S, Tais A, Ihorst G, Janoschke M, Schubach F, Aries P, Bergner R, Bremer JP, Görl N, Gutdeutsch E, Hellmich B, Henes J, Hoyer BF, Kangowski A, Kötter I, Krusche M, Magnus T, Metzler C, Müller-Ladner U, Schaier M, Schönermarck U, Thiel J, Unger L, Venhoff N, Weinmann-Menke J, Petersen J, Lamprecht P, Iking-Konert C. Wallmeier P, et al. Clin Exp Rheumatol. 2024 Apr;42(4):895-904. doi: 10.55563/clinexprheumatol/d3o0gu. Epub 2024 Apr 19. Clin Exp Rheumatol. 2024. PMID: 38683207 Free article.
OBJECTIVES: Giant cell arteritis (GCA) is one of the most common forms of vasculitis. There is an abundance of studies which are conducted in a randomised controlled trial setting but limited with respect to cohort size and follow-up time. ...After three mont …
OBJECTIVES: Giant cell arteritis (GCA) is one of the most common forms of vasculitis. There is an abundance of studies which are cond …
Prediction model for developing neuropsychiatric systemic lupus erythematosus in lupus patients.
Feng SY, Su LC, Liu XY, Qin Z, Fu L, Huang AF, Xu WD. Feng SY, et al. Clin Rheumatol. 2024 Jun;43(6):1881-1896. doi: 10.1007/s10067-024-06970-z. Epub 2024 Apr 27. Clin Rheumatol. 2024. PMID: 38676758
OBJECTIVE: This study aimed to construct a predictive model for assessing the risk of development of neuropsychiatric systemic lupus erythematosus (NPSLE) among patients with SLE based on clinical, laboratory, and meteorological data. METHODS: A total of 2232 SLE patients …
OBJECTIVE: This study aimed to construct a predictive model for assessing the risk of development of neuropsychiatric systemic lupus erythem …
Giant Cell Arteritis.
Ness T, Nölle B. Ness T, et al. Klin Monbl Augenheilkd. 2024 May;241(5):644-652. doi: 10.1055/a-2252-3371. Epub 2024 Apr 9. Klin Monbl Augenheilkd. 2024. PMID: 38593832 Review. English, German.
Giant cell arteritis (GCA) is the most common primary vasculitis and is associated with potential bilateral blindness. Neither clinical nor laboratory evidence is simple and unequivocal for this disease, which usually requires rapid and reliable diagnosis and therap …
Giant cell arteritis (GCA) is the most common primary vasculitis and is associated with potential bilateral blindness. Neither cli
Cranial involvement in giant cell arteritis.
Bosch P, Espigol-Frigolé G, Cid MC, Mollan SP, Schmidt WA. Bosch P, et al. Lancet Rheumatol. 2024 Jun;6(6):e384-e396. doi: 10.1016/S2665-9913(24)00024-9. Epub 2024 Apr 1. Lancet Rheumatol. 2024. PMID: 38574747 Review.
Since its first clinical description in 1890, extensive research has advanced our understanding of giant cell arteritis, leading to improvements in both diagnosis and management for affected patients. ...Classification criteria for giant cell arteritis, as well as recommen …
Since its first clinical description in 1890, extensive research has advanced our understanding of giant cell arteritis, leading to i …
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey.
Jarrot PA, Mirouse A, Ottaviani S, Cadiou S, Salmon JH, Liozon E, Parreau S, Michaud M, Terrier B, Gavand PE, Trefond L, Lavoiepierre V, Keraen J, Rekassa D, Bouldoires B, Weitten T, Roche D, Poulet A, Charpin C, Grobost V, Hermet M, Pallure M, Wackenheim C, Karkowski L, Grumet P, Rogier T, Belkefi N, Pestre V, Broquet E, Leurs A, Gautier S, Gras V, Gilet P, Holubar J, Sivova N, Schleinitz N, Durand JM, Castel B, Petrier A, Arcani R, Gramont B, Guilpain P, Lepidi H, Weiller PJ, Micallef J, Saadoun D, Kaplanski G. Jarrot PA, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2334084. doi: 10.1080/21645515.2024.2334084. Epub 2024 Apr 2. Hum Vaccin Immunother. 2024. PMID: 38563792 Free PMC article.
We conducted a national in-depth analysis including pharmacovigilance reports and clinical study to assess the reporting rate (RR) and to determine the clinical profile of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in COVID-19-vaccinated individuals …
We conducted a national in-depth analysis including pharmacovigilance reports and clinical study to assess the reporting rate (RR) an …
3,781 results